Mackenzie Financial Corp Trillium Therapeutics Inc. Transaction History

Mackenzie Financial Corp

  • $71.6 Billion
  • Q2 2025

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
N/A
-21,420 Closed
0 $0
Q3 2021

Nov 08, 2021
SELL
N/A
-8,862 Reduced 29.26%
21,420 $376,000
Q2 2021

Aug 11, 2021
BUY
N/A
8,870 Added 41.43%
30,282 $293,000
Q1 2021

May 14, 2021
BUY
N/A
21,412 New
21,412 $229,000
Q4 2020

Feb 10, 2021
SELL
N/A
-10,114 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
N/A
10,114 New
10,114 $144,000

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email